Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 25, 2026, the Company held its 2026 Annual Meeting. As of the close of business on May 6, 2026, the record date for the Annual Meeting, 83,830,457 shares of common stock of the Company were issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, the stockholders voted on five proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on May 13, 2026. Stockholders approved each of the proposals presented for a vote. The tables below set forth the number of votes cast for and against, and the number of abstentions or broker non-votes, for each matter voted upon by the Company's stockholders.
Proposal 1. The election of ten directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
Robert Selander
|
74,453,187
|
1,442,014
|
35,205
|
3,822,795
|
|
Scott Cutler
|
75,542,815
|
353,789
|
33,802
|
3,822,795
|
|
Stephen Neeleman, M.D.
|
75,032,571
|
864,875
|
32,960
|
3,822,795
|
|
Adrian Dillon
|
74,828,471
|
1,066,059
|
35,876
|
3,822,795
|
|
Evelyn Dilsaver
|
74,762,646
|
1,131,196
|
36,564
|
3,822,795
|
|
William Gassen
|
75,701,238
|
193,566
|
35,602
|
3,822,795
|
|
Debra McCowan
|
74,683,289
|
1,209,511
|
37,606
|
3,822,795
|
|
Rajesh Natarajan
|
75,770,615
|
124,053
|
35,738
|
3,822,795
|
|
Stuart Parker
|
75,662,488
|
231,609
|
36,309
|
3,822,795
|
|
Gayle Wellborn
|
75,005,354
|
811,661
|
113,391
|
3,822,795
|
Proposal 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. There were no broker non-votes for this proposal.
|
|
|
|
|
|
|
|
|
|
|
For
|
Against
|
Abstain
|
|
79,249,985
|
449,600
|
53,616
|
Proposal 3. The approval, on a non-binding, advisory basis, of the fiscal 2026 compensation paid to the Company's named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
74,032,348
|
1,852,931
|
45,127
|
3,822,795
|
Proposal 4. The approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
75,717,841
|
190,964
|
21,601
|
3,822,795
|
Proposal 5. The approval of the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|
73,514,259
|
2,366,900
|
49,247
|
3,822,795
|